Congratulations to Randal Kaufman (Randal J. Kaufman Lab) for being recognized in Clarivate’s 2023 Highly Cited Researchers list. Kaufman is among 2,669 American researchers given the honor in 2023. #HighlyCited2023 bit.ly/3G83WcF

Attend Focus On: Cancer and learn from leading experts on the inner workings of cancer’s toughest challenges. Featuring Laura D. Attardi, Ph.D., of Stanford Medicine and hosted by Brooke Emerling. Learn more: bit.ly/47KXN1U

Tobacco, alcohol and opioids—all substances plaguing the nation with addiction. Our scientists are working diligently to combat this public health crisis. Visit the full article for a glimpse of the addiction research happening at Sanford Burnham Prebys. bit.ly/49DXKq4

Unique DNA loops found outside regular chromosomes are linked to poor clinical outcomes in aggressive childhood brain cancers. The new study, led by Lukas Chavez and published in Nature Genetics, may transform the treatment of these rare cancers. More: bit.ly/49DsuHK

Congratulations to David A. Brenner, MD, president and CEO of Sanford Burnham Prebys for being recognized by the San Diego Business Journal as one of San Diego's most influential leaders. San Diego Business Journal

Hudson Freeze joined an international panel of genetics experts on CAD deficiency: Beyond the genetics—a podcast offered by the Journal of Inherited Metabolic Disease (The Journal of Inherited Metabolic Disease). Full podcast here: bit.ly/49MOWi3

Former Sanford Burnham Prebys postdoc, Eric Lau, Ph.D., urges scientific institutions to become proactive against discrimination and to speak out against oppression while prioritizing diversity, equity and inclusion. Read more: bit.ly/470F16d Nature Reviews Cancer Eric Lau

Sanford Burnham Prebys scientists suggest a new strategy to trick pancreatic tumors into death by feeding them a copycat of an important nutrient which starves them of the fuel necessary for survival. Read more: bit.ly/3ZRWwDd Cosimo Commisso

Graduate student Jiaqian (Emily) Wu of the Cosford lab receives Melvin and Phyllis McCardle Clause Scholarship to discover innovative treatments for Alzheimer’s disease. Read more: bit.ly/3rzOrqf

Zeroing in on hepatic myofibroblasts while simultaneously addressing the underlying cause(s) of liver damage may be the key to reversing liver fibrosis. A new review by David Brenner, M.D., describes the emerging therapeutic approach. More: bit.ly/46tENUC

Lukas Chavez, Ph.D., has received $3.2 million from the NIH to study how circular extrachromosomal DNA found in cancer cells drive deadly pediatric brain tumors. Learn more: bit.ly/466e3tX Lukas Chavez

Stop & Talk is now available! Don’t miss the latest episode as Svasti Haricharan sits down with The Conrad Prebys Foundation to discuss her journey to health disparities research and the effects of race on cancer outcomes. Listen now: bit.ly/46acr1O svastiharicharan

Cosimo Commisso, Ph.D., receives a $1 million grant from the Department of Defense 🇺🇸 to advance the research of a small molecule that kills pancreatic cancer cells by disrupting their pH equilibrium. More: bit.ly/3sFiQU1 Cosimo Commisso

Breast Cancer - Cancer Center Open House

Timothy Huang receives $2.6 million gift from the NIH to decode an Alzheimer’s disease conundrum. The gift will support Huang in his quest to understand the link between TREM2, a protein found in the brain’s immune cells, & the development of the disease: bit.ly/3RaVEHq

Attend Focus On: Cancer Metabolism and learn from leading experts on the inner workings of cancer’s toughest challenges. Featuring Heather Christofk, Ph.D., of UCLA and hosted by Cosimo Commisso. Learn more: bit.ly/4762cwz

Join Sanford Burnham Prebys for an unforgettable night at Curebound’s Concert for Cures: Ed Sheeran will perform a benefit concert to accelerate cancer research in San Diego. Tickets are on sale now at curebound.org. Curebound

A study led by Alex Colas and Karen Ocorr has created a multiplatform experimental model that can accurately identify genes associated with atrial fibrillation—the most common age-related cardiac arrhythmia. Learn more: bit.ly/3s6nKsY

Researchers at Sanford Burnham Prebys have found that age and sex may matter a lot when it comes to the consequences of many types of cancer. Read the full interview with Svasti Haricharan published in Diagnostics World News: bit.ly/3P1XZmS svastiharicharan Diagnostics World

Sanford Burnham Prebys' Cancer Center receives rare & prestigious Merit Extension Award from National Cancer Institute to pursue a strategic plan that includes establishing a drug development pipeline, recruiting top talent & developing DEI-centric training programs. More: bit.ly/451Q6U1